Closed · W81XWH-14-MSRP-IIPA · CFDA 12.420 · Discretionary
DoD Multiple Sclerosis Investigator-Initiated Partnership Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- September 3, 2014
- Close date
- 2
- Expected awards
The verdict
DoD Multiple Sclerosis Investigator-Initiated Partnership Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 2 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.
- Varies
- award range
- Closed
- application status
- 2
- expected awards
- 12.420
- CFDA program
Archived opportunity record
DoD Multiple Sclerosis Investigator-Initiated… is closed (last close September 3, 2014). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed September 3, 2014
Est. Total Funding
$3,840,000
Expected Awards
2
Instrument
Grant
Description
The MSRP Investigator-Initiated Partnership Award (IIPA) mechanism is being offered for the first time in FY14 with the goal of attracting promising investigators and new perspectives on a research project to improve MS patient care and/or quality of life.The Investigator-Initiated Partnership Award supports the development of translational research collaborations among no more than three independent investigators (known as partners), who synergistically combine efforts to address a central problem or question in MS. The application should demonstrate each partner’s contribution and criticality to the project, which together bring a new perspective to MS research and create the synergy of the team. A proposed project in which one of the partners merely supplies tissue samples or access to patients does not meet the intent of this mechanism. The success of the project must depend on the contribution of unique skills and expertise of each partner. The application must include plans clearly outlining the process for interactions between all partners. The plans must include communication structure and meeting schedules, coordination of research milestones, progress updates, plans for data transfer and analysis, and sharing of results. Additionally, multi-institutional applications must provide an intellectual property plan to resolve potential intellectual and material property issues and to remove institutional barriers that might interfere with achieving the high levels of cooperation needed to ensure the successful completion of the project.Observations that drive a research project may be derived from a laboratory discovery, population-based studies, or a clinician’s firsthand knowledge of patients and anecdotal data. The ultimate goal is to move an observation forward into clinical application. Important aspects of the Investigator-Initiated Partnership Award are as follows:1. Partnership: The partnership must consist of no more than three partners; the three partners include the Initiating PI and one or two Partnering PIs. The application should clearly describe each partner’s role, expertise, and why they are essential to the project. At least one partner must be a clinician, and at least one partner must be a research scientist. At least one partner must have experience in either MS research and/or MS patient care, and at least one partner must be from outside of the MS field. Experience in MS research is defined by a history of previous or current MS research funding and peer-reviewed MS publications. The proposed collaboration must be new in that the proposed team as a whole cannot have collaborated previously. Some, but not all, partners of the proposed collaboration may have collaborated with each other in the past. Previous collaboration is defined by a history of past or current shared research funding and/or joint peer-reviewed publication of research. Co-authorship on review papers and/or symposium summaries is not considered previous research collaboration.2. Impact: Applications should describe both the potential short- and long-term outcomes of the proposed research and their potential impact on improving MS patient care and/or quality of life.3. Preliminary Data: Preliminary data to support the feasibility of the research project and research approaches are required; however, these data do not need to come from the MS research field.
Catch-all / unrestricted eligibility mark · W81XWH-14-MSRP-IIPA
Grants.gov marks DoD Multiple Sclerosis Investigator-Initiated… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDMRP Help Desk 301-682-5507
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
What to do next
DoD Multiple Sclerosis Investigator-Initiated… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |